The World Health Organization and UNITAID, with the support of Medicines Law & Policy, published a briefing paper on legal instruments that Member States can use to promote public health and access to key therapies for COVID-19 within the framework of their multilateral trade obligations and rights and according to their national legislation and level of development.

Click on the following link for more information: